US House Passes FDA 2020 Budget In Minibus Bill, Moving It To Senate After $5M Boost In Telemedicine Funds
US appropriations legislation that would give the FDA’s device center an 8% raise over last year was passed by the US House on 25 June as part of a five-bill “minibus” package. It will move to the Senate for consideration after the US Independence Day recess. Among the last-minute amendments to H.R. 3055 was a $5m boost for telemedicine.
You may also be interested in...
The US House on 25 July signed off on a two-year budget deal for FY 2020 and 2021 raising the federal debt ceiling, and allowing funding for FDA and other federal agencies to go forward.
House Wants FDA Action On Non-Pharma Pain Relievers, Breast Density Reports, Pediatric Devices In 2020
The US House Appropriations Committee wants the FDA to foster development of non-pharma and non-opioid pain alternatives, complete mammography breast density reporting regulations, and use an additional $1m Congress would provide to conduct pediatric device trials, among other device initiatives outlined in its 2020 budget bill passed on 4 June.
A $2.2tn coronavirus stimulus package signed into law by President Trump on 27 March will distribute billions of dollars to federal agencies – including the FDA, the CDC and the FEMA – to hasten approvals of new diagnostics, medical ventilators, respirators and other medtech supplies, conduct more testing of potential COVID-19 patients, and quickly distribute medical supplies where needed most.